Innoviva ROA 2006-2019 | INVA

Current and historical return on assets (ROA) values for Innoviva (INVA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Innoviva ROA for the three months ending December 31, 2019 was 23.89%.
Innoviva ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-12-31 $0.16B $0.73B 24.00%
2019-09-30 $0.38B $0.68B 61.24%
2019-06-30 $0.38B $0.64B 74.44%
2019-03-31 $0.40B $0.59B 91.17%
2018-12-31 $0.40B $0.55B 109.85%
2018-09-30 $0.19B $0.28B 60.27%
2018-06-30 $0.17B $0.34B 48.62%
2018-03-31 $0.15B $0.28B 41.79%
2017-12-31 $0.13B $0.37B 35.22%
2017-09-30 $0.10B $0.39B 26.34%
2017-06-30 $0.09B $0.37B 24.31%
2017-03-31 $0.07B $0.39B 18.95%
2016-12-31 $0.06B $0.38B 15.57%
2016-09-30 $0.04B $0.37B 9.83%
2016-06-30 $0.02B $0.38B 4.46%
2016-03-31 $-0.01B $0.39B -1.18%
2015-12-31 $-0.02B $0.41B -4.45%
2015-09-30 $-0.04B $0.44B -8.37%
2015-06-30 $-0.06B $0.46B -11.05%
2015-03-31 $-0.11B $0.49B -20.64%
2014-12-31 $-0.17B $0.52B -29.56%
2014-09-30 $-0.20B $0.55B -33.20%
2014-06-30 $-0.23B $0.61B -35.81%
2014-03-31 $-0.20B $0.61B -31.57%
2013-12-31 $-0.17B $0.68B -26.84%
2013-09-30 $-0.15B $0.67B -27.18%
2013-06-30 $-0.14B $0.60B -28.66%
2013-03-31 $-0.14B $0.59B -32.11%
2012-12-31 $-0.02B $0.37B -5.26%
2012-09-30 $-0.02B $0.38B -7.62%
2012-06-30 $-0.02B $0.40B -6.90%
2012-03-31 $-0.01B $0.22B -3.01%
2011-12-31 $-0.12B $0.26B -40.00%
2011-09-30 $-0.10B $0.28B -31.82%
2011-06-30 $-0.09B $0.30B -30.29%
2011-03-31 $-0.08B $0.32B -30.80%
2010-12-31 $-0.08B $0.33B -32.75%
2010-09-30 $-0.09B $0.21B -39.73%
2010-06-30 $-0.09B $0.23B -41.61%
2010-03-31 $-0.09B $0.25B -43.41%
2009-12-31 $-0.09B $0.18B -43.31%
2009-09-30 $-0.08B $0.18B -37.62%
2009-06-30 $-0.08B $0.21B -34.21%
2009-03-31 $-0.08B $0.22B -33.64%
2008-12-31 $-0.09B $0.24B -35.07%
2008-09-30 $-0.11B $0.26B -44.49%
2008-06-30 $-0.12B $0.28B -51.80%
2008-03-31 $-0.14B $0.30B -64.44%
2007-12-31 $-0.16B $0.16B -77.85%
2007-09-30 $-0.16B $0.20B -71.54%
2007-06-30 $-0.17B $0.21B -67.33%
2007-03-31 $-0.17B $0.25B -59.23%
2006-12-31 $-0.17B $0.26B -55.33%
2006-09-30 $-0.17B $0.29B -58.47%
2006-06-30 $-0.17B $0.32B -63.67%
2006-03-31 $-0.16B $0.33B -65.51%
2005-12-31 $-0.14B $0.23B -62.51%
Sector Industry Market Cap Revenue
Basic Materials Gold Miners $1.531B $0.261B
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Barrick Gold (GOLD) Canada $38.119B 41.23
Franco-Nevada (FNV) Canada $22.570B 81.07
Newcrest Mining (NCMGY) Australia $14.930B 0.00
Agnico Eagle Mines (AEM) Canada $12.472B 53.01
AngloGold Ashanti (AU) South Africa $9.176B 0.00
Sibanye Gold (SBGL) South Africa $8.184B 0.00
Kirkland Lake Gold (KL) Canada $7.647B 13.27
Kinross Gold (KGC) Canada $7.472B 17.53
Royal Gold (RGLD) United States $7.153B 51.95
Gold Fields (GFI) South Africa $6.182B 0.00
Yamana Gold (AUY) Canada $4.429B 35.85
Alamos Gold (AGI) Canada $2.726B 31.68
Harmony Gold Mining (HMY) South Africa $2.230B 0.00
Osisko Gold Royalties (OR) Canada $1.642B 49.67
Eldorado Gold (EGO) Canada $1.638B 165.50
Iamgold (IAG) Canada $1.468B 0.00
Pretium Resources (PVG) Canada $1.448B 14.46
Acacia Mining (ABGLF) United Kingdom $1.267B 28.09
DRDGOLD (DRD) South Africa $0.508B 0.00
Gold Reserve (GDRZF) United States $0.172B 0.00
Jaguar Mining (JAGGF) Canada $0.128B 0.00